Related Experiment Video
Updated: Aug 8, 2026

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Chronic morphine-mediated adenylyl cyclase superactivation is attenuated by the Raf-1 inhibitor, GW5074
Xu Yue1, Eva V Varga, Dagmar Stropova
1Department of Medical Pharmacology, University of Arizona, Tucson, AZ 85724, USA.
Abstract:
The utility of morphine for the treatment of chronic pain is limited by the development of analgesic tolerance. Adenylyl cyclase (AC) superactivation, induced by chronic opioid agonist administration, is regarded as one of the molecular mechanisms leading to tolerance. In the present work, we tested the role of Raf-1 in morphine-mediated AC superactivation in CHO cells stably expressing the human micro-opioid receptor. We found that pretreatment of CHO cells stably expressing the human micro-opioid receptor with the selective Raf-1 inhibitor, 3-(3,5-dibromo-4-hydroxybenzylidene)-5-iodo-1,3-dihydroindol-2-one (GW5074, 10 microM, 60 min) completely abolished chronic morphine-mediated AC superactivation (P < 0.01). This finding indicates that Raf-1 may have a crucial role in compensatory feedback regulation of cellular cAMP levels by clinically important opioid analgesics.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
Opioid Receptors: Overview
GPCR Desensitization
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Desensitization and Tachyphylaxis
Several...
